Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Sacramento
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Sacramento, CA

Studies commonly pay $75 to $4,500 per completed study

638 clinical trials are currently recruiting participants within 30 miles of Sacramento. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

638studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Sacramento right now

Top 25 of 638 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
University of California Davis Comprehensive Cancer Center — Sacramento, California (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
University of California, Davis Comprehensive Cancer Center — Sacramento, California (1.7 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
University of California Davis (UC Davis) Comprehensive Cancer Center — Sacramento, California (1.7 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
Sutter Institute for Medical Research — Sacramento, California (1.7 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Retinal Consultants Medical Group — Sacramento, California (1.7 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Kaiser Permanente Downtown Commons — Sacramento, California (1.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Mercy Cancer Center - Sacramento — Sacramento, California (1.7 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Heart Failure Phase 3 Interventional 1,500 participants sought
CON-10024 Sacramento, CA Investigational Site — Sacramento, California (1.7 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06024746)

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection Recurrence Phase 2 Interventional 20 participants sought
UC Davis Medical Center — Sacramento, California (1.7 mi) · Sponsor: Acurx Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07513285)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Retinal Consultants Med Group — Sacramento, California (1.7 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Sutter Medical Center Sacramento — Sacramento, California (1.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate Phase 2 Interventional 1,431 participants sought
GMC Clinical Research — Folsom, California (17.5 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07415044)

Pilot Study Exploring the Effects of Rhythmic Auditory Stimulation on Gait in People With Motor Incomplete Spinal Cord Injury

Spinal Cord Injury N/A Interventional 15 participants sought
UC Davis Point West — Sacramento, California (1.7 mi) · Sponsor: University of California, Davis
See eligibility & contact on ClinicalTrials.gov (NCT07674927)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
Kaiser Permanente - Sacramento Medical Center — Sacramento, California (1.7 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds

Scarring N/A Interventional 50 participants sought
University of California, Davis - Dermatology Department — Sacramento, California (1.7 mi) · Sponsor: University of California, Davis
See eligibility & contact on ClinicalTrials.gov (NCT06288009)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
Sutter Institute for Medical Research — Roseville, California (16.0 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06793215)

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Urothelial Cancer Phase 2, Phase 3 Interventional 470 participants sought
Sutter Health - Sutter Institute for Medical Research — Sacramento, California (1.7 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07106762)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Mercy Cancer Center - Sacramento — Sacramento, California (1.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

Surgical Site Infection Phase 4 Interventional 2,700 participants sought
University of California, Davis Medical Center — Sacramento, California (1.7 mi) · Sponsor: University of California, Irvine
See eligibility & contact on ClinicalTrials.gov (NCT05586776)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Kaiser Permanente - Roseville ( Site 0081) — Roseville, California (16.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis Phase 3 Interventional 180 participants sought
California Pacific Medical Center — Sacramento, California (1.7 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06744920)
Actively enrolling

Studies you may be able to join near Sacramento

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Sacramento

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Sutter Institute for Medical Research: Sutter Medical Center, Sacramento

★ 4.5
2801 Capitol Ave #400, Sacramento, CA 95816
(916) 453-5898
"Nice and friendly, they called me at my appointment time. Not a lot of seating in the waiting room."
— stephen scharp, 4★

UC Davis Clinical and Translational Science Center

★ 1.8
2921 Stockton Blvd #2305, Sacramento, CA 95817
(916) 703-9184

UC Davis Health - Participate in Clinical Trials

2921 Stockton Blvd, Sacramento, CA 95817
(855) 823-1660

Integrative Research Institute

★ 5.0
4825 J St Ste 100, Sacramento, CA 95819
(916) 775-5080
"Great team of specialists. Very nice staff."
— Angelina Begas, 5★

Center for Healthcare Policy & Research

4480 2nd Ave, Sacramento, CA 95817
(916) 734-7918

UC Davis Center for Precision Medicine and Data Sciences

Education Building, 4610 X St Suite 3126, Sacramento, CA 95817

Clinical Trials Research

★ 5.0
3750 Auburn Blvd Ste A, Sacramento, CA 95821
(916) 487-8230
"I asked for a business location and it popped right up."
— Barbara McGarvey, 5★

UC Davis Cypress Bldg

★ 3.5
2221 Stockton Blvd, Sacramento, CA 95817
(916) 734-2011
"This lab is hit and miss for decent service. Some of the people who work there are rude and they are SLOW! Some are super chatty, like we don't have …"
— Ambulatory, 1★

UC Davis Health Alzheimer's Disease Research Center

1651 Alhambra Blvd #200a, Sacramento, CA 95816
(916) 734-5496

Clinical trials in Sacramento: what's recruiting

The Sacramento area currently has 638 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Sacramento, the most active research areas are:

  • Cancer & Oncology12 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular2 studies
  • Immune & Skin2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Sacramento, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Sacramento

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Sacramento participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Sacramento?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Sacramento, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Sacramento?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Sacramento?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Sacramento.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Sacramento typically complete one or two studies per year.

Paid clinical trials near Sacramento

Other metros within reach

Elk Grove, CA629 Roseville, CA639 Stockton, CA99 Fairfield, CA345 Antioch, CA451 Concord, CA1,509 Vallejo, CA1,499 Modesto, CA98

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Sacramento Bladder Issues Due To Spinal Cord Injury in Sacramento All conditions

More of CA

Long Beach3,361 Torrance3,253 Fullerton3,246 Anaheim3,181 Garden Grove3,176 Pomona3,138 Glendale2,959 Los Angeles2,949 Huntington Beach2,863 Santa Clarita2,390 Hayward2,268 Oakland2,257

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts